Skip to main content
Erschienen in: Endocrine 2/2021

24.05.2021 | Original Article

Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma

verfasst von: Ziyuan Liu, Wenzhong Zhou, Rulai Han, Wei Zhou, Jie Zhang, Haorong Li, Zhihan Wan, Yan Jin, Liyun Shen, Yulin Zhou, Shu Wang, Xi Chen, Lei Ye

Erschienen in: Endocrine | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Widespread use of sensitive ultrasound examination led to an increasing detection of medullary thyroid microcarcinoma (micro-MTC). This prospective study evaluated the diagnostic accuracy of Fine-needle Aspiration Biopsy Cytology (FNAB-C) and calcitonin assay in Fine-needle Aspiration Biopsy wash-out fluid (FNAB-CT) in thyroid nodules less than 1 cm with elevated serum calcitonin(sCT).

Methods

87 thyroid nodules from 60 patients with elevated sCT (>10 pg/ml) were included and 51 were thyroid nodules less than 1cm. FNAB-CT and FNAB-C were performed to distinguish medullary thyroid carcinoma (MTC) lesions before surgery, histopathologic diagnoses served as main reference standards.

Results

FNAB-CT had a greater performance over FNAB-C for preoperative diagnosis of MTC (diagnostic accuracy: 98.85 vs 61.90%, sensitivity: 98.55 vs 55.07%, specificity: 100 vs 97.44%), especially for micro-MTC: FNAB-C established a sensitivity and diagnostic accuracy of 48.78 and 58% respectively, while FNAB-CT reached 97.56% sensitivity and 98.04% diagnostic accuracy.

Conclusions

FNAB-CT demonstrated high diagnostic accuracy in diagnosing micro-MTC. Patients with microscopic thyroid nodules and elevated sCT level should perform FNAB-CT to exclude the diagnosis of MTC lesions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat L. Ceolin, M. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer 26, R499–R518 (2019)CrossRef L. Ceolin, M. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer 26, R499–R518 (2019)CrossRef
2.
Zurück zum Zitat H.S. Kazaure, S.A. Roman, J.A. Sosa, Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer 118, 620–7 (2012)CrossRef H.S. Kazaure, S.A. Roman, J.A. Sosa, Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer 118, 620–7 (2012)CrossRef
3.
Zurück zum Zitat H. Kwon, W.G. Kim, T.Y. Sung, M.J. Jeon, D.E. Song, Y.M. Lee et al. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. J. Surg. Oncol. 113, 152–8 (2016)CrossRef H. Kwon, W.G. Kim, T.Y. Sung, M.J. Jeon, D.E. Song, Y.M. Lee et al. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. J. Surg. Oncol. 113, 152–8 (2016)CrossRef
4.
Zurück zum Zitat A. Machens, H. Dralle, Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening. Eur. J. Endocrinol. 175, 219–28 (2016)CrossRef A. Machens, H. Dralle, Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening. Eur. J. Endocrinol. 175, 219–28 (2016)CrossRef
5.
Zurück zum Zitat R.W. Randle, C.J. Balentine, G.E. Leverson, J.A. Havlena, R.S. Sippel, D.F. Schneider et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef R.W. Randle, C.J. Balentine, G.E. Leverson, J.A. Havlena, R.S. Sippel, D.F. Schneider et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef
6.
Zurück zum Zitat F. Torresan, C. Mian, E. Cavedon, M. Iacobone, Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Langenbecks Arch. Surg. 404, 411–419 (2019)CrossRef F. Torresan, C. Mian, E. Cavedon, M. Iacobone, Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Langenbecks Arch. Surg. 404, 411–419 (2019)CrossRef
7.
Zurück zum Zitat N. Choi, W.J. Moon, J.H. Lee, J.H. Baek, D.W. Kim, S.W. Park, Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results. Acta Radio. 52, 312–6 (2011)CrossRef N. Choi, W.J. Moon, J.H. Lee, J.H. Baek, D.W. Kim, S.W. Park, Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results. Acta Radio. 52, 312–6 (2011)CrossRef
8.
Zurück zum Zitat A. Machens, H. Dralle, Biological relevance of medullary thyroid microcarcinoma. J. Clin. Endocrinol. Metab. 97, 1547–53 (2012)CrossRef A. Machens, H. Dralle, Biological relevance of medullary thyroid microcarcinoma. J. Clin. Endocrinol. Metab. 97, 1547–53 (2012)CrossRef
9.
Zurück zum Zitat G.C. Yang, K. Fried, P.H. Levine, Detection of medullary thyroid microcarcinoma using ultrasound-guided fine needle aspiration cytology. Cytopathology 24, 92–8 (2013)CrossRef G.C. Yang, K. Fried, P.H. Levine, Detection of medullary thyroid microcarcinoma using ultrasound-guided fine needle aspiration cytology. Cytopathology 24, 92–8 (2013)CrossRef
10.
Zurück zum Zitat J.H. Kim, J.S. Pyo, W.J. Cho, Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis. World J. Surg. 41, 2551–2558 (2017)CrossRef J.H. Kim, J.S. Pyo, W.J. Cho, Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis. World J. Surg. 41, 2551–2558 (2017)CrossRef
11.
Zurück zum Zitat R. Elisei, V. Bottici, F. Luchetti, G. Di Coscio, C. Romei, L. Grasso et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163–8 (2004)CrossRef R. Elisei, V. Bottici, F. Luchetti, G. Di Coscio, C. Romei, L. Grasso et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163–8 (2004)CrossRef
12.
Zurück zum Zitat G. Costante, D. Meringolo, C. Durante, D. Bianchi, M. Nocera, S. Tumino et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450–5 (2007)CrossRef G. Costante, D. Meringolo, C. Durante, D. Bianchi, M. Nocera, S. Tumino et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450–5 (2007)CrossRef
13.
Zurück zum Zitat G. Costante, D. Meringolo, Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67, 273–280 (2020)CrossRef G. Costante, D. Meringolo, Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67, 273–280 (2020)CrossRef
14.
Zurück zum Zitat H. Vierhapper, B. Niederle, C. Bieglmayer, K. Kaserer, S. Baumgartner-Parzer, Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15, 1267–72 (2005)CrossRef H. Vierhapper, B. Niederle, C. Bieglmayer, K. Kaserer, S. Baumgartner-Parzer, Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15, 1267–72 (2005)CrossRef
15.
Zurück zum Zitat S.A. Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015)CrossRef S.A. Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015)CrossRef
16.
Zurück zum Zitat I.M. Boschin, F. Torresan, A. Toniato, M. Zane, E.C. Ide, G. Pennelli et al. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45, 448–53 (2014)CrossRef I.M. Boschin, F. Torresan, A. Toniato, M. Zane, E.C. Ide, G. Pennelli et al. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45, 448–53 (2014)CrossRef
17.
Zurück zum Zitat H. Kwon, W.G. Kim, Y.M. Choi, E.K. Jang, M.J. Jeon, D.E. Song et al. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 82, 598–603 (2015)CrossRef H. Kwon, W.G. Kim, Y.M. Choi, E.K. Jang, M.J. Jeon, D.E. Song et al. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 82, 598–603 (2015)CrossRef
18.
Zurück zum Zitat C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef
19.
Zurück zum Zitat M.B. Niederle, C. Scheuba, P. Riss, A. Selberherr, O. Koperek, B. Niederle, Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30, 974–984 (2020)CrossRef M.B. Niederle, C. Scheuba, P. Riss, A. Selberherr, O. Koperek, B. Niederle, Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30, 974–984 (2020)CrossRef
20.
Zurück zum Zitat C. Nozières, L. Chardon, B. Goichot, F. Borson-Chazot, V. Hervieu, K. Chikh et al. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. Eur. J. Endocrinol. 174, 335–41 (2016)CrossRef C. Nozières, L. Chardon, B. Goichot, F. Borson-Chazot, V. Hervieu, K. Chikh et al. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. Eur. J. Endocrinol. 174, 335–41 (2016)CrossRef
21.
Zurück zum Zitat P. Trimboli, G. Treglia, L. Guidobaldi, F. Romanelli, G. Nigri, S. Valabrega et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin. Endocrinol. (Oxf.) 82, 280–5 (2015)CrossRef P. Trimboli, G. Treglia, L. Guidobaldi, F. Romanelli, G. Nigri, S. Valabrega et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin. Endocrinol. (Oxf.) 82, 280–5 (2015)CrossRef
22.
Zurück zum Zitat C.Y. Liu, A. Bychkov, S. Agarwal, Y. Zhu, J.F. Hang, C.R. Lai et al. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region. Diagn. Cytopathol. 49, 60–69 (2021)CrossRef C.Y. Liu, A. Bychkov, S. Agarwal, Y. Zhu, J.F. Hang, C.R. Lai et al. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region. Diagn. Cytopathol. 49, 60–69 (2021)CrossRef
23.
Zurück zum Zitat M.P. Pusztaszeri, M. Bongiovanni, W.C. Faquin, Update on the cytologic and molecular features of medullary thyroid carcinoma. Adv. Anat. Pathol. 21, 26–35 (2014)CrossRef M.P. Pusztaszeri, M. Bongiovanni, W.C. Faquin, Update on the cytologic and molecular features of medullary thyroid carcinoma. Adv. Anat. Pathol. 21, 26–35 (2014)CrossRef
24.
Zurück zum Zitat K.S. Dyhdalo, D.J. Chute, Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines. Cancer Cytopathol. 126, 397–405 (2018)CrossRef K.S. Dyhdalo, D.J. Chute, Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines. Cancer Cytopathol. 126, 397–405 (2018)CrossRef
25.
Zurück zum Zitat H.J. Moon, E. Son, E.K. Kim, J.H. Yoon, J.Y. Kwak, The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann. Surg. Oncol. 19, 52–9 (2012)CrossRef H.J. Moon, E. Son, E.K. Kim, J.H. Yoon, J.Y. Kwak, The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann. Surg. Oncol. 19, 52–9 (2012)CrossRef
26.
Zurück zum Zitat C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef
27.
Zurück zum Zitat F. Boi, I. Maurelli, G. Pinna, F. Atzeni, M. Piga, M.L. Lai et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 92, 2115–8 (2007)CrossRef F. Boi, I. Maurelli, G. Pinna, F. Atzeni, M. Piga, M.L. Lai et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 92, 2115–8 (2007)CrossRef
28.
Zurück zum Zitat T. Kudo, A. Miyauchi, Y. Ito, Y. Takamura, N. Amino, M. Hirokawa, Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17, 635–8 (2007)CrossRef T. Kudo, A. Miyauchi, Y. Ito, Y. Takamura, N. Amino, M. Hirokawa, Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17, 635–8 (2007)CrossRef
29.
Zurück zum Zitat P. Trimboli, F. Rossi, R. Baldelli, O. Laurenti, G. Nigri, C. Ventura et al. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn. Cytopathol. 40, 394–8 (2012)CrossRef P. Trimboli, F. Rossi, R. Baldelli, O. Laurenti, G. Nigri, C. Ventura et al. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn. Cytopathol. 40, 394–8 (2012)CrossRef
30.
Zurück zum Zitat P. Trimboli, G. Nigri, F. Romanelli, D.D. Cicciarella Modica, A. Crescenzi, S. Valabrega et al. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp. Clin. Endocrinol. Diabetes 120, 234–7 (2012)CrossRef P. Trimboli, G. Nigri, F. Romanelli, D.D. Cicciarella Modica, A. Crescenzi, S. Valabrega et al. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp. Clin. Endocrinol. Diabetes 120, 234–7 (2012)CrossRef
31.
Zurück zum Zitat C. Diazzi, B. Madeo, E. Taliani, L. Zirilli, S. Romano, A.R. Granata et al. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocr. Pr. 19, 769–79 (2013)CrossRef C. Diazzi, B. Madeo, E. Taliani, L. Zirilli, S. Romano, A.R. Granata et al. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocr. Pr. 19, 769–79 (2013)CrossRef
32.
Zurück zum Zitat U. Mousa, A. Gursoy, H. Ozdemir, G. Moray, Medullary thyroid carcinoma in a patient with Hashimoto’s thyroiditis diagnosed by calcitonin washout from a thyroid nodule. Diagn. Cytopathol. 41, 644–6 (2013)CrossRef U. Mousa, A. Gursoy, H. Ozdemir, G. Moray, Medullary thyroid carcinoma in a patient with Hashimoto’s thyroiditis diagnosed by calcitonin washout from a thyroid nodule. Diagn. Cytopathol. 41, 644–6 (2013)CrossRef
33.
Zurück zum Zitat P. Trimboli, N. Cremonini, L. Ceriani, E. Saggiorato, L. Guidobaldi, F. Romanelli et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin. Endocrinol. (Oxf.) 80, 135–40 (2014)CrossRef P. Trimboli, N. Cremonini, L. Ceriani, E. Saggiorato, L. Guidobaldi, F. Romanelli et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin. Endocrinol. (Oxf.) 80, 135–40 (2014)CrossRef
34.
Zurück zum Zitat C. de Crea, M. Raffaelli, D. Maccora, C. Carrozza, G. Canu, G. Fadda et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngol. Ital. 34, 399–405 (2014)PubMed C. de Crea, M. Raffaelli, D. Maccora, C. Carrozza, G. Canu, G. Fadda et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngol. Ital. 34, 399–405 (2014)PubMed
35.
Zurück zum Zitat A. Suzuki, M. Hirokawa, N. Takada, M. Higuchi, A. Ito, N. Yamao et al. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr. J. 64, 1099–1104 (2017)CrossRef A. Suzuki, M. Hirokawa, N. Takada, M. Higuchi, A. Ito, N. Yamao et al. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr. J. 64, 1099–1104 (2017)CrossRef
36.
Zurück zum Zitat B. Marques, N. Cunha, R.G. Martins, A.R. Elvas, J. Couto, J. Santos et al. Lymph node metastases of medullary thyroid cancer: role of calcitonin in the washout fluid of fine-needle aspiration. Int J. Endocrinol. 2020, 9267972 (2020)CrossRef B. Marques, N. Cunha, R.G. Martins, A.R. Elvas, J. Couto, J. Santos et al. Lymph node metastases of medullary thyroid cancer: role of calcitonin in the washout fluid of fine-needle aspiration. Int J. Endocrinol. 2020, 9267972 (2020)CrossRef
37.
Zurück zum Zitat P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, L. Irwig et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527 (2015)CrossRef P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, L. Irwig et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527 (2015)CrossRef
38.
Zurück zum Zitat J.Y. Kwak, K.H. Han, J.H. Yoon, H.J. Moon, E.J. Son, S.H. Park et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260, 892–9 (2011)CrossRef J.Y. Kwak, K.H. Han, J.H. Yoon, H.J. Moon, E.J. Son, S.H. Park et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260, 892–9 (2011)CrossRef
39.
Zurück zum Zitat E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27, 1341–1346 (2017)CrossRef E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27, 1341–1346 (2017)CrossRef
40.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef
Metadaten
Titel
Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma
verfasst von
Ziyuan Liu
Wenzhong Zhou
Rulai Han
Wei Zhou
Jie Zhang
Haorong Li
Zhihan Wan
Yan Jin
Liyun Shen
Yulin Zhou
Shu Wang
Xi Chen
Lei Ye
Publikationsdatum
24.05.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02759-1

Weitere Artikel der Ausgabe 2/2021

Endocrine 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.